Hypertension

BLinatumomab and iNKT in Relapsed B-Cell ALL
Conditions: B-Cell ALL; ALL (Acute B-Lymphoblastic Leukemia); Philadelphia Chromosome-Negative Lymphoblastic Leukemia; CD19-positive B-cell Acute

Interventions: Biological: Invariant Natural Killer T Cell Therapy

Sponsors: UNC Lineberger Comprehensive Cancer Center; MiNK Therapeutics

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 13, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Trial Comparing CPDMA Versus Standard Breadloafing in WLE Specimens of Stage 1-II Cutaneous Melanoma
Conditions: Cutaneous Melanoma, Stage II; Cutaneous Melanoma; Acral Melanoma

Interventions: Diagnostic Test: Wide Local Excision

Sponsors: University of Nebraska

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 12, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Phase II De-Escalation Study of Metronomic Decitabine/Cedazuridine Plus Venetoclax in AML
Conditions: Acute Myeloid Leukaemia (AML)

Interventions: Drug: Venetoclax, Decitabine/Cedaruridine; Drug: decitabine/cedazuridine

Sponsors: Rutgers, The State University of New Jersey

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 11, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Post-exercise Blood Pressure With Inorganic Nitrate

Conditions: Obese Individuals; Central Adiposity
Interventions: Dietary Supplement: Beetroot Juice – Active + Exercise; Dietary Supplement: Beetroot juice placebo + Exercise; Dietary Supplement: Beetroot Juice – Active + No exercise; Dietary Supplement: Beetroot juice placebo+ No exercise
Sponsors: University of Virginia
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 10, 2026Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Coronary Artery Calcium (CAC) Testing in Primary Care

Conditions: ASCVD; ASCVD Management; Coronary Artery Calcium; Hyperlipidemia
Interventions: Other: Our Practice Advisory (OPA)
Sponsors: Weill Medical College of Cornell University; Merck Sharp & Dohme LLC
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 10, 2026Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ATI-105 in Healthy Adults

Conditions: Friedreich Ataxia; Cardiomyopathies; Central Nervous System Diseases; Neuromuscular Diseases; Mitochondrial Diseases; Mitochondrial Dysfunction; Genetic Disease
Interventions: Drug: ATI-105; Drug: Placebo
Sponsors: Adjuvia Therapeutics, Inc.; Quotient Sciences
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 10, 2026Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Glycemic Impact of NNS Via the Gut Microbiome

Conditions: Prediabetes
Interventions: Dietary Supplement: Sucralose
Sponsors: Tufts University; Tufts Medical Center
Enrolling by invitation

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 10, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication

Conditions: Overweight; Obesity; Type 2 Diabetes
Interventions: Drug: Tirzepatide; Drug: Zenagamtide
Sponsors: Novo Nordisk A/S
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 10, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
CKD Awareness, Referrals, Education, and Support Intervention for Early-Stage CKD

Conditions: Chronic Kidney Disease; Diabetes
Interventions: Behavioral: CKD Awareness, Referrals, Education, and Support (CARES); Behavioral: Attention control
Sponsors: University of Illinois at Chicago; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Chicago
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 10, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
KPSC MNT Pilot RCT

Conditions: Type 2 Diabetes
Interventions: Behavioral: Diabetes Medical Nutrition Therapy (DM MNT) Pilot
Sponsors: Kaiser Permanente
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 10, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine